We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Immupharma Plc | LSE:IMM | London | Ordinary Share | GB0033711010 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.02 | -0.92% | 2.16 | 2.12 | 2.20 | 2.20 | 2.13 | 2.20 | 733,951 | 16:35:21 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | -3.81M | -0.0114 | -1.87 | 7.1M |
Date | Subject | Author | Discuss |
---|---|---|---|
25/7/2018 11:15 | ^^^^^^^^^^^^^^^^^^^^ | brad44 | |
25/7/2018 10:37 | Any break out from here on the back of vaguely positive news will see an over reaction to the upside imo. Too many day traders and lth looking for 35-50p range which imo is fair value for the IP and reformulation potential alone. | rathean | |
25/7/2018 10:00 | FYI Gents. Immupharma (LON:#IMM) says it is in discussion with some pharmaceutical companies Published: Tuesday, July 24, 2018 10:24 PM PDT [link] ...hTTps://twitter.com | tidy 2 | |
25/7/2018 09:32 | Chung....your full of dung | kop202 | |
25/7/2018 08:22 | 10p soon.Nothing to fill the gap after the drug failure.Managers still drawing full pay.CEO also took Alizyme into administration . | ken chung | |
25/7/2018 07:17 | Just popped in, nothing doing here, I expect some have made up their losses here investing in (AOR) Nothing to be excited about here. | ny boy | |
25/7/2018 07:10 | Ken Chung is so short that when he went to meet santa he said, "Go back to work!" | a_2_b | |
25/7/2018 06:21 | Would 'have' hit us! The youth of today.... | nobbygnome | |
24/7/2018 23:39 | Chinese man and a gnome walk into bar...Well it's lucky we're short otherwise that would of hit us. | a_2_b | |
24/7/2018 23:37 | Well it's either that or lose the house. I just have a very dark sense of humour. You're obviously new to this stock and haven't had the pleasure of knowing these guys for too long. | a_2_b | |
24/7/2018 20:23 | What does a gnome and a chinese man have in common?They're both short | a_2_b | |
23/7/2018 22:21 | Chung your so Rung | kop202 | |
23/7/2018 22:20 | Cheerful Charlie Chung | kop202 | |
23/7/2018 19:31 | 10p soon, then 5p. | ken chung | |
23/7/2018 14:18 | Probably best to PM him or post on the MTFB thread, some very knowledgeable shareholders oer there.IMM starting to show on a couple of buy signals, as always it's a binary play but very close to historic lows. Could represent a good buy and hold entry point imo dyor ofc. | rathean | |
23/7/2018 10:15 | Nobby, I follow your posts as you usually show proven insight. Off the topic of IMM, MTFB has an antibiotic which has passed phase III, and has been submitted for FDA approval with fast track priority. Yet it is languishing near its lows. Is the market telling us that this is another AIM share destined to fail? Your comments would be appreciated. | uncleoswald | |
21/7/2018 14:53 | Hmm? Sounds like ken, another broken record. Already in opti been in for several years, not looking for tiny percentages like you. I thought or so you keep telling us all, how intelligent you are, then why are you posting stupid idiotic posts on here. We are all aware of the situation and are awaiting news. | brad44 | |
21/7/2018 14:14 | I don't know if you guys have seen where OPTI got to at the end of last week with much further to go IMHO! Meanwhile back at IMM the market is telling you that nothing good is expected from Lupuzor as the price dribbles away. Don't forget, waterloo (former guru here now ramping SUMM) thinks Lupuzor is a zombie drug! I couldn't agree more.... Nobby | nobbygnome |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions